Clinical Trials for Gene Solutions

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Gene Solutions

Clinical Trials (9)

NCT07126626
Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer
N/ANot yet recruiting
1,184 participants
Started: Aug 18, 2025 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT06929910
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
N/ARecruiting
200 participants
Started: Apr 9, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06863038
Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam
N/ANot yet recruiting
572 participants
Started: Mar 17, 2025 · Completed: Nov 30, 2027
2 conditions2 sponsors1 location
NCT06391749
Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE)
N/AEnrolling by invitation
1,000 participants
Started: Jul 30, 2024 · Completed: Jul 31, 2026
5 conditions2 sponsors1 location
NCT06589388
ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer
N/ARecruiting
100 participants
Started: May 21, 2024 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06385366
Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women by Non-invasive Prenatal Test
N/AEnrolling by invitation
1,105 participants
Started: May 10, 2024 · Completed: Nov 6, 2025
4 conditions2 sponsors1 location
NCT06227728
Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
N/ARecruiting
50 participants
Started: Mar 22, 2024 · Completed: Dec 31, 2026
7 conditions1 sponsor2 locations
NCT06167460
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
N/ARecruiting
50 participants
Started: Dec 4, 2023 · Completed: Dec 1, 2025
5 conditions1 sponsor1 location
NCT06087120
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
N/ARecruiting
125 participants
Started: Sep 16, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor3 locations